Clinical Trial Update: Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tetrathiomolybdate to standard treatment for primary biliary cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• Tetrathiomolybdate (tetrathiomolybdate)

Snippet

Sponsor: George Brewer | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: COMPLETED